BAGE4

gene
On this page

Also known as CT2.4

Summary

BAGE4 (BAGE family member 4, HGNC:15730) is a protein-coding gene on chromosome 21p11.1 not on reference assembly, encoding B melanoma antigen 4 (Q86Y28). Unknown.

Predicted to be located in extracellular region.

Source: NCBI Gene 85317 — RefSeq curated summary.

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:15730
Approved symbolBAGE4
NameBAGE family member 4
Location21p11.1 not on reference assembly
Locus typegene with protein product
StatusApproved
AliasesCT2.4
Entrez85317

Gene structure

Transcript identifiers

Ensembl transcripts: 0

RefSeq mRNA: 0 — MANE Select: None

Canonical transcript exons

None — 0 exons

Expression profiles

Top tissues by expression

0 total, by Bgee expression score (0-100, higher = more expressed):

Regulation

Is transcription factor: no

Cross-species orthologs

0 orthologs

Protein

Protein identifiers

B melanoma antigen 4Q86Y28 (reviewed: Q86Y28)

Alternative names: Cancer/testis antigen 2.4

All UniProt accessions (0):

UniProt curated annotations — full annotation on UniProt →

Function. Unknown. Candidate gene encoding tumor antigens.

Subcellular location. Secreted.

Tissue specificity. Not expressed in normal tissues except in testis. Expressed in melanoma, bladder and lung carcinomas.

Miscellaneous. The ancestral BAGE gene was generated by juxtacentromeric reshuffling of the KMT2C/MLL3 gene. The BAGE family was expanded by juxtacentromeric movement and/or acrocentric exchanges. BAGE family is composed of expressed genes that map to the juxtacentromeric regions of chromosomes 13 and 21 and of unexpressed gene fragments that scattered in the juxtacentromeric regions of several chromosomes, including chromosomes 9, 13, 18 and 21.

Similarity. Belongs to the BAGE family.

RefSeq proteins (0): (*=MANE)

Domains & families (InterPro)

IDNameType
IPR012530BAGE-likeFamily

Pfam: PF08180

UniProt features (2 total): signal peptide 1, chain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q86Y28-F172.890.16

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 0 (showing top):

GO Biological Process (0):

GO Molecular Function (0):

GO Cellular Component (1): extracellular region (GO:0005576)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure1

Protein interactions and networks

STRING

0 interactions, top by confidence (×1000):

IntAct

2 interactions, top by confidence:

ABTypeScore
ECE1BAGE4psi-mi:“MI:0915”(physical association)0.370

ESM2 similar proteins: A0A0U1RRA0, A0T0A9, A2C0D1, A2CCQ0, A2CCQ1, A5GQF4, A5GWI2, B0C6T2, B2JA13, B8HTR1, D5AP83, E9Q9R3, O10337, P04123, P0C420, P0C421, P0C422, P0CZ12, P0DJZ4, P13293, P35089, P35090, P35091, P35098, P35099, P35101, P35104, P35105, P51769, P52587, P80107, P80587, P80654, Q00644, Q0IDJ7, Q10XU6, Q20F20, Q2JS34, Q2KS19, Q32RU4

Diamond homologs: Q13072, Q86Y27, Q86Y28, Q86Y29, Q86Y30

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

0 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance0
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

0 predictions. Top by Δscore:

AlphaMissense

0 scored. Top likely-pathogenic:

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

2 total (human), top 2 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Acidincreases methylation1
Aflatoxin B1decreases methylation1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.